Recent research progress on natural small molecule bibenzyls and its derivatives in Dendrobium species

Eur J Med Chem. 2020 Oct 15:204:112530. doi: 10.1016/j.ejmech.2020.112530.

Li He ¹, Qian Su ², Lan Bai ³, Meifeng Li ¹, Juanru Liu ¹, Xiaomei Liu ¹, Cunyan Zhang ¹, Zhongliang Jiang ⁴, Jun He ⁵, Jianyou Shi ⁶, Shan Huang ⁷, Li Guo ⁸

Affiliations

1 The Ministry of Education Key Laboratory of Standardization of Chinese Herbal Medicines, State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
2 Health Management Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, 610072, China.
3 Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, China.
4 Department of Hematology, Miller School of Medicine, University of Miami, Miami, USA.
5 State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu, 610041, China.
6 Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, China. Electronic address: shijianyoude@126.com.
7 Cancer Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China. Electronic address: shan.huang@msn.com.
8 The Ministry of Education Key Laboratory of Standardization of Chinese Herbal Medicines, State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. Electronic address: gli64@sina.com.

PMID: 32711292 DOI: 10.1016/j.ejmech.2020.112530

Abstract

Orchidaceous plant Dendrobium genus is often used as a tonic, and its phenolic components have attracted attention for its anti-tumor and anti-diabetic complications. Bibenzyls is one of the essential phenolic active ingredients in the Dendrobium genus. At present, 89 bibenzyl derivatives have been extracted and identified from 46 Dendrobium species. The activity studies have shown that 42 compounds have pharmaceutical activity. Among them, 23 compounds showed antitumor activity; 7 compounds showed anti-diabetes and its complications activity; 10 compounds exhibited neuroprotective effects; 18 compounds showed antioxidant effects; 11 compounds had anti-inflammatory activity; 3 compounds had Antiplatelet aggregation effects; 3 compounds had Antibacterial and Antiviral effects. The Bibenzyls is small-molecular compounds of natural origin and widely sourced. Previous studies showed that the bibenzyls has good anti-tumor, anti-diabetes and its complications, and neuroprotective effects, and it has great potential for treating tumors, diabetes and its complications, Alzheimer's disease (AD) and Parkinson's disease (PD). Additionally, compounds such as moscatilin (1), gigantol (2) and chrysotoxine (3) have been further studied as lead compounds, and compounds exhibited therapeutical effects had been synthesized. Enough pieces of evidences have shown that the Bibenzyls have good development prospects. This article reviews the pharmacological effects of bibenzyls in Dendrobium species and provides an idea for its further development.

Keywords

Bibenzyls; Biological activities; Dendrobium species.

Name
Email *

	Sorry, but the email address you supplied was invalid.